Literature DB >> 7063522

Characterization of [3H]-adenosine binding to media membranes of hog carotid arteries.

W Schütz, G Brugger.   

Abstract

Binding of [3H]-adenosine to a microsomal fraction derived from media strips of hog carotid arteries was studied by a centrifugation technique. Specific binding was very rapid, readily and completely reversible, and temperature dependent. Under the chosen conditions of incubation, at 4 degrees C and in the presence of deoxycoformycin, about 95% of the bound radioactivity was chromatographically identified as adenosine. Scatchard analysis revealed a small number (1.7 pmol/mg protein) of high affinity (KD = 0.23 mumol/l) and a large number (21.6 pmol/mg protein) of low affinity binding sites (KD = 4.3 mumol/l). 5'-Phosphorylated adenosine compounds. 5'-deoxyadenosine, 2-chloroadenosine, and adenosine-5'-N-ethylcarboxamide, all derivatives of adenosine with pronounced vasodilatory properties, were most potent in displacing [3H]-adenosine from its binding sites with IC50 values ranging from 1.8 to 14.3 mumol/l. However, 2-chloroadenosine and (--)N6-phenylisopropyladenosine were weaker competitors of binding than adenosine, which disagrees with the pharmacological findings. Moreover, the IC50 of aminophylline was much higher than the concentration required for half-maximal inhibition of the biological actions of adenosine. This partial lack of specificity may be due to nonreceptor binding of [3H]-adenosine at the low affinity sites.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7063522     DOI: 10.1159/000137573

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  2 in total

1.  [3H]Adenosine binding to rat mast cells--pharmacologic and functional characterization.

Authors:  D L Marquardt; S I Wasserman
Journal:  Agents Actions       Date:  1985-09

2.  Adenosine receptor agonists: binding and adenylate cyclase stimulation in rat liver plasma membranes.

Authors:  W Schütz; E Tuisl; O Kraupp
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-04       Impact factor: 3.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.